Title of article
Intravitreal Bevacizumab (Avastin) as an Adjuvant Therapy for Choroidal Carcinoid Metastasis
Author/Authors
Karimi, Saeed Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences - Torfe Medical Center, Tehran, Iran , Arabi, Amir Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences - Torfe Medical Center, Tehran, Iran , Shahraki, Toktam Ophthalmic Research Center - Shahid Beheshti University of Medical Sciences - Torfe Medical Center, Tehran, Iran
Pages
3
From page
420
To page
422
Abstract
Purpose: To report a case of choroidal carcinoid metastasis with neovascularization of the optic disc and macular edema that was treated with three sessions of intravitreal anti‑vascular endothelial growth factor (anti-VEGF) as an adjuvant therapy with photodynamic therapy (PDT).
Methods: A 16‑year‑old patient with a diagnosis of lung carcinoid tumor presented to an ophthalmology clinic with a complaint of decreased
vision in his right eye. Fundus examination revealed choroidal carcinoid metastasis in addition to neovascularization of the optic disc. Macular
optical coherence tomography revealed cystoid macular edema and subretinal fluid. The patient was treated with PDT in addition to three
sessions of intravitreal anti‑VEGF injections.
Results: Following the treatment, the new vessels regressed, and visual acuity improved. Furthermore, central retinal thickness reduced
significantly. The tumor size reduced significantly over a follow‑up period of 6 weeks.
Conclusion: Choroidal carcinoid metastasis may be complicated by neovascularization of optic disc, which responds favorably to intravitreal injections of bevacizumab.
Keywords
Carcinoid , Choroidal metastasis , Vascular endothelial growth factors
Journal title
Journal of Current Ophthalmology
Serial Year
2020
Record number
2714994
Link To Document